Medicare Fraud Probes Keep DOJ Hopping

John Commins, for HealthLeaders Media , August 15, 2011

The civil lawsuit essentially reiterates the allegations brought forward in the criminal trial.

The fraud, which prosecutors say began in 2003 and continued until late 2009, was brought by whistleblowers Dora Figueroa and Francisca Pages, who both worked for Justice at Pacific Coast Hematology, The women could receive up to 25% of the settlement, as part of the whistleblower statute.

MD Oncologist Pleads Guilty to Purchasing Misbranded Drugs

Isabella Martire, MD, age 52, of Laurel, MD, an oncologist in solo practice, has pleaded guilty to introducing a misbranded drug into interstate commerce.

According to Martire's plea agreement, in 2010, federal law enforcement investigators began investigating a pharmaceutical wholesaler based in England concerning allegations that the company was importing into the United States prescription drugs approved and labeled for use only outside the United States. Further investigation revealed that Martire purchased nearly $200,000 of misbranded prescription drugs from the company in 2010.

Martire used the misbranded drugs to treat her cancer patients. She sought reimbursement from Medicare, Medicaid, TRICARE, federal employee health benefit plans and private health insurers for reimbursement of the cost of those drugs. The cost savings Martire realized by purchasing the misbranded drugs was at least $790,600 in 2010.

Martire faces a maximum penalty of one year in prison followed by a year of supervised release when she is sentenced on Oct. 17, prosecutors said.

1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "Medicare Fraud Probes Keep DOJ Hopping"

nancee (2/18/2012 at 8:38 AM)
Martire is back practicing oncology in md how is that possible




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.